BRM5014 Therapeutic approaches and biotechnology
Faculty of Medicine, Nursing and Health Sciences
BRM5014 Therapeutic approaches and biotechnology is a level 5, 6-credit-point, postgraduate unit from the Faculty of Medicine, Nursing and Health Sciences, offered in 2025 in Semester 1 at Clayton, Malaysia and Suzhou (SEU). It has no prerequisites.
- Credit points
- 6
- Offered in 2025
- Semester 1
- Clayton, Malaysia, Suzhou (SEU)
- Assessment
- No exam
- 3 tasks
This is the 2025 handbook entry. See the 2027 entry.
Reviews
No reviews yetNo reviews yet. Be the first to review BRM5014.
Requisites
Before BRM5014
No prerequisites or corequisites besides the enrolment rules below.
After BRM5014
No unit lists BRM5014 as a prerequisite in the 2025 handbook.
Enrolment rules
Overview
This unit covers the fundamentals and principles of modern biotechnology-based therapeutic approaches for treating and managing diseases. You will learn about the cellular and molecular basis of drug actions that underpin new drug development. The general principles of the pathway for developing a new drug or biotechnological device for therapeutic use will be outlined.
You will gain knowledge of drug discovery research methodology through designing suitable experiments to investigate the pharmacological properties of novel compounds, and interpreting data arising from these experiments. The unit also provides an overview of different sectors in the biotechnology industry, and their role in the development, commercialisation and regulation of therapeutics.
Offerings in 2025
| Teaching period | Campus | Mode |
|---|---|---|
| First semester | Clayton | Blended |
| First semester | Malaysia | On campus |
| First semester | Suzhou (SEU) | On campus |
Assessment
- Written reports (3,000 words total)Written50%
- In-semester tests (MCQ and SAQ, online - total 3 hours)Quiz / Test30%
- Group oral presentation (20 mins with peer evaluation 10 mins) (Individual report 300-500 words)Presentation20%
Learning outcomes
When you finish this unit, you should be able to:
- 1
Explain advanced pharmacodynamics and pharmacokinetics concepts.
- 2
Critically appraise the therapeutic efficacy and safety of drugs with regards to their pharmacodynamics and pharmacokinetics profiles.
- 3
Design in vitro and in vivo experiments to investigate the pharmacological properties of novel compounds.
- 4
Select appropriate statistical approaches to compare the pharmacological properties of drugs.
- 5
Apply knowledge of the key sectors of the biotechnology industry and their roles in drug development, commercialisation and regulation to identify career opportunities in the industry.
Workload and teaching
- Lectures24 hours
- Workshops22 hours
- Teaching approachCase-based teaching
6 hours of directed learning including 4 contact hours per week, 2 hours of lectures and 2 hours of workshop/ tutorial/ practical per week and 6 hours of self-directed learning including private study per week.
For full details of the teaching approach to this unit, please refer to Moodle.
Learning resources
Required resources
See Moodle for details about required resources.
Contacts
- Unit Coordinators
- Dr Chau Khuong
- Dr B Saatheeyavaane Bhuvanendran Pillai
- Andy Liang
- Chief Examiners
- Professor Graham Lieschke
- Dr Ammu Radhakrishnan
- Muhammad Khan
- Dr Chau Khuong
Common questions
What are the prerequisites for BRM5014?
BRM5014 has no prerequisites, but enrolment rules apply.
When is BRM5014 offered?
In 2025, BRM5014 runs in Semester 1 at Clayton, Malaysia and Suzhou (SEU).
Does BRM5014 have an exam?
No. BRM5014 has 3 assessment tasks and no exam.